Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype which lacks the estrogen receptor (ER) and progesterone receptor (PR) expression and also lacks overexpression of the human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.